Illness	Number of cases
Mental and behavioural disorders due to use of alcohol (F10.2)	280
Depressive episode - Major depressive disorder single episode severe without psychotic features (F32.2)	152
Schizophrenia - Paranoid schizophrenia (F20.0)	137
Recurrent depressive disorder - Major depressive disorder recurrent severe without psychotic features (F33.2)	100
Borderline personality disorder (F60.31)	79
Reaction to severe stress and adjustment disorders - Acute stress reaction (F43.0)	43
Delirium not induced by alcohol and other psychoactive substances (F05.1)	35
Reaction to severe stress and adjustment disorders (F43.1)	30
Mental and behavioural disorders due to use of alcohol (F10.0)	27
Depressive episode - Major depressive disorder single episode severe with psychotic features (F32.3)	21

Top 10 treatments

Treatment	Number
(9-649.0)	2.151
(9-649.40)	1.642
Standard treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-607)	910
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with two characteristics (9-618)	794
(9-649.31)	605
(9-649.20)	560
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with one characteristic (9-617)	451
(9-649.41)	411
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with three characteristics (9-619)	336
(9-649.30)	313

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2900

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Asthma bronchiale

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ06
CQ31
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
177	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
117	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
80	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)	In Zusammenarbeit mit dem Universitätsklinikum Hamburg Eppendorf UKE und dem Universitätsklinikum Schleswig-Holstein - Campus Kiel.
Participation in multi-centre Phase I/II studies	Phase II: CIRCULATE (AIO-KRK-0217) Colon-Ca., randomisierte Doppelblindstudie zum Vergleich von Wirksamkeit, Pharmakokinetik, Sicherheit u. Immunogenität zwischen ABP 234+Keytruda® (Pembrolizumab) bei Pat. mit fortgeschrittenem/metastasiertem nicht-plattenepithelialem nicht-kleinzelligem Lungenkrebs
Project-related cooperation with colleges and universities	Hochschulstandort Neumünster
Editors of scientific journals/textbooks
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Participation in multi-centre phase III/IV studies	Phase III: FIRE-9-PORT/AIO, metastasiertes Kolorektal-Ca., Phase IV: INGA–fortgeschrittenes/metastasiertes Adeno-Ca. Magen, AEG/Ösophagus, FINN-NSCLC,Multizentrische Beobachtungsstudie zur Beurteilung d. Ergebnisse von Durvalumab-basierten Therapien bei hepatobiliären Krebserkrankungen, MMML-Predict
Lectureships / teaching posts at colleges and universities
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB10	Midwife (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB09	Speech therapist (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB19	Nursing professionals	65 Ausbildungsplätze
HB17	Auxiliary nurse (m/f)	25 Ausbildungsplätze
HB03	Physical therapist / physiotherapist (m/f)	Absolvierung des obligatorischen Praktikums im FEK.
HB06	Occupational therapist (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB05	Medical technical radiology assistant (MTRA) (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB12	Medical technical laboratory assistant (MTLA) (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB16	Dietician (m/f)	Absolvierung des obligatorischen Praktikums im FEK